Repurposing Semaglutide and Liraglutide for Alcohol Use Disorder [PMID: 39535805] Laboratory literature summary: Repurposing Semaglutide and Liraglutide for Alcohol Use Disorder
As more people seek lasting solutions, GLP-1 weight loss programs are becoming a key option for managing weight and improving health
Why GLP-1s affect digestion GLP-1 is a naturally occurring hormone from the gut that regulates how quickly food leaves the stomach and when you feel full
It is not a controlled substance but exists in a regulatory gray area
In the landmark STEP 1 trial (Once-Weekly Semaglutide in Adults with Overweight or Obesity, Wilding and colleagues, New England Journal of Medicine , 2021), 1,961 adults who took weekly semaglutide (2.4 mg) plus lifestyle support lost a mean of 14.9% of their body weight over 68 weeks, compared with 2.4% on placebo, and 86% achieved at least 5% weight loss